[Stellar Pharmaceuticals-KY] April 2026 Revenue 0.02 Billion (Year-on-Year Decrease of -57.1%)

Company Code: 6550 Company Name: Stellar Pharmaceuticals-KY Industry: Biotechnology and Healthcare Data Month: 2026-04 Current Month Revenue: 1,668 thousand NT$ (0.02 billion NT$) Year-on-Year Change: -57.1%

Keywords: Monthly Revenue, Biotechnology and Healthcare Industry.

Stellar Pharmaceuticals-KY (Stock Code: 6550) has reported its financial results for April 2026. The company, which is part of the Biotechnology and Healthcare sector, generated a revenue of NT$1.668 million for the month. This figure represents a substantial year-on-year decline of 57.1%. The keywords associated with this announcement highlight the monthly revenue performance and the company's industry focus.